Fannin Innovation’s Managing Partner discusses strategies, challenges in biotech investment, and what sets Fannin’s model apart in the industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback